Compare CDRE & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDRE | BHVN |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2021 | 2022 |
| Metric | CDRE | BHVN |
|---|---|---|
| Price | $33.65 | $10.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | ★ $39.67 | $29.08 |
| AVG Volume (30 Days) | 365.5K | ★ 2.0M |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.21% | N/A |
| EPS Growth | 13.33 | ★ 26.08 |
| EPS | ★ 1.02 | N/A |
| Revenue | ★ $610,308,000.00 | N/A |
| Revenue This Year | $23.72 | N/A |
| Revenue Next Year | $6.89 | N/A |
| P/E Ratio | $32.34 | ★ N/A |
| Revenue Growth | ★ 7.53 | N/A |
| 52 Week Low | $28.22 | $7.48 |
| 52 Week High | $48.76 | $24.06 |
| Indicator | CDRE | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 48.11 | 59.65 |
| Support Level | $31.58 | $9.41 |
| Resistance Level | $34.25 | $11.92 |
| Average True Range (ATR) | 1.21 | 0.67 |
| MACD | 0.63 | 0.24 |
| Stochastic Oscillator | 84.53 | 89.89 |
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.